261Quality improvement: Interdisciplinary teams start your binders!  by Sorensen, S.L. et al.
Data Management & Oncology Nursing Abstracts 
258 
EFFICACY OF CHLORHEXIDINE DRESSINGS FOR THE PREVENTION 
OF CATHETER ENTRY SITE INFECTIONS: RESULTS FROM A PROSPEC- 
TIVE RANDOMISED TRIAL IN HAEMATOLOGY PATIENTS RECEIVING 
CHEMOTHERAPY 
Sanders, 7.; Chambers, S.; R~th, S.; Pattoll, 14'~ Hae~n~tology, 
Christchm'ch Hospital, Christchurch, New Zealamt. 
Ainu Exit site infections in tunnelled central catheters are a fre- 
quent source of morbidity in neutropenic patients. These usually 
require antibiotic therapy with the attendant costs of administra- 
tion, promotion of antibiotic resistance and adverse effects. This 
study investigates the question of whether chlorhexidine dressings 
reduce the rates of such infections. Methods: We have conducted 
a prospective randomised trial of these dressings (Biopatch) 
against he current British standard of care. The standard arm was 
a dry dressing until the site is dry and free from ooze and then no 
dressing. An infected site was defined as reddening, pain and ten- 
derness at the exit site sufficient o cause the attending clinician to 
prescribe ant imicrobial  therapy, i14 patients treated with 
chemotherapy were randomised to one of the two treatment arms 
and the same dressings were used for the duration of catheter life. 
Double lmnen Hickman catheters were used in 106(92%). 55 
patients received standard dressings and 59 chlorhexidine dress- 
ings. Results: 93% of patients became neutropenic. (neutrophil 
count < 1.0x 109/I.) The distribution of age, sex, primary diagnosis, 
number of treatment episodes and duration of neutropenia were 
similar between the two groups. The primary endpoint was e~t 
site infection, which occurred in 36.6% patients with the standard 
dressing and 5.08% with the biopatch dressing. Combined exit 
site, tunnel and luminal infections occurred in 9/55 16.3% and 
2/59 3.3% respectively. There was no difference between the two 
groups in the reasons for catheter emoval, bacteraemic episodes 
or catheter life. Conclusions: Exit site infections were a common 
problem in neutropenic patients treated in the standard manner 
but were signif icantly reduced with chlorhexidine dressings 
(Biopatch). This suggests that these dressings hould be strongly 
considered in routine management of neutropenic episodes. 
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VALIDATION OF THE NURSING DIAGNOSIS ANXIETY AS EXPERIENCED 
BY ADULT BONE MARROW TRANSPLANT PATIENTS FROM THE PER- 
SPECTIVE OF THE PATIENT, SIGNIFICANT OTHER AND NURSE 
Yom~g, L.K.I; Pol~in, if.e; Todd, S.'; Sinl, m~cak, S.L. ~- 1. Na'rsi1~g, 
MSOE, 3/lilwallkee, ~VI; 2. Froedtert Memorial Lnthera~ Hospital, 
34il'waukee, ~fq. 
The purpose of this study was to validate the nursing diagnosis 
anxiety, as experienced by adult bone marrow transplant patients. 
A descriptive, longitudinal design was chosen, data from patients, 
significant others and nurses were collected on the first day of 
conditioning, twenty-five days later, and one hundred days post 
transplant. Patients who experienced autologous r allogeneic 
transplants were included in the study. Findings included a signiif- 
icant differnce between the stai anxiety scores. The stai anxiety, 
scores revealed moderate anxiety at time one, low anxiety at time 
two and moderate anxiety at time three. A Significant positive cor- 
relation was found between the patient stai scores and graphic 
scores and the stai scores and DCT scores at time one and two, 
and between the DCT scores and graphic scores at time two. A 
significant positive correlation was found between the patient dct 
scores and significant other dct scores at time one and two. 18 
critical and supporting defining charcteristics were iidentified by 
the patient, 20 identified by the signicant other and 9 by the 
nurse. Significant others were found to be a valid resource in iden~ 
tification of the paients' level of anxiety, as welI as the defining 
characteristics of anxiety, a tool that consists of the critical and 
supporting defining characteristics of anxiety, as experienced by 
bone marrow transplant patients, is recommended for further 
deveh)pment and testing. Use of a visual analog scale to assess 
anxiety in clinical environments hould be considered. (Key 
Words: anxiety, bone morrow transplantation, nursing diagnosis) 
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THE TANDEM AUTOLOGOUS AND MATCHED RELATED NONMYE- 
LOABLATIVE HSCT PATIENT: WHAT'S DIFFERENT? 
Anderso~l, LA. Seattle Cancer Cave Allim~ce, Seattle, H"~q. 
The patient eligible for the tandem transplant typically presents 
in a more compromised state of health due to the process of 
recovering from mobilization, debulking chemotherapy, hemopo- 
etic stem cells storage, and autologous transplantation. There are 
key differences frona the ablative transplant in the appropriate 
pat ient and caregiver education regarding the evaluation and 
work-up. In many treatment centers the pre and post transplant 
management is connnonly conducted strictly in the out patient 
arena. This necessitates compressed time for patient and caregiver 
education, coordination of clinics and routine testing. Encourag- 
ing the use of existing and complex support systems to report 
complications and or concerns is essential. Some of the Clinical 
issues which will be discussed include: The patient will likely have 
a Short Double Lmnen central ine, and be taking warfiarin. This 
needs to be discontinued when platelet count < 50K. Warfarin's 
efficacy is affected with the addition of Cyclosporine (CSP) Com~ 
bined immunosuppression with the use of both Mycophenolate 
Mofeti l  (MMF) and CSP up to 56 days can be challenging to 
those who find it difficult to swallow pills. Unlike thc standard 
aIlogenic transplant, serum CSP levels are kept in the 500 - 600 
ng/mL range. FaciaI flushing, burning or tender sldn on hands 
and or feet may not resolve while these levels are maintained nr 
ing the first 30 days of transplant. Reassurance to both the care- 
giver and patient hat this effect is normal and expected, and not 
an indication that there is 'something wrong'. Even those patients 
with prior compromised renal fimction will be maintained with 
potentially renal to,'dc serum levels of CSP. This *nay develop into 
kidney failure necessitating dialysis. At the time of the discharge 
work-up, usually 80 to 100 days post transplant, it is not unusual 
for the patient o be off" immunosuppressive drugs. This places the 
patient at a greater isk of developing acute graft versus host dis- 
ease (GVHD) in a setting that may not be familiar with diagnos- 
ing GVHD and re- implementing immunosuppressive therapy. 
This paper will illuminate the necessity and details involved in 
caring for patients and caregivers who are experiencing a tandem 
transplant. 
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QUALITY IMPROVEMENT: INTERDISCIPLINARY TEAMS START YOUR 
BINDERS! 
Sorensen, S.L.; Rhodes, B.; Samamego, C.; H(alker, ft.; Peck, N.; Ador- 
netto, D. Apheresis, MDdmteTson Cancer Center, ltonston, T~. 
Challenged with developing a Quality Improvement Plan in the 
Apheresis area of the Blood and Marrow Transplantation Pro- 
gram, the initial step was to discover what was presently being 
done. The Apheresis nurses identified two areas of concern, the 
patient satisfaction survey and chart audits. The patient satisfiac- 
tion survey was a joint survey distributed to both outpatient Blood 
and Marrow Transplant patients and those in Apheresis. The 
nursing staff re-wrote the survey to obtain information relevant o 
the Apheresis refit. The survey was distributed montly and the 
results were trended and discussed at staff meetings. The results 
were graphed and displayed on a "story board" using the institu- 
tional quality improvement process of "Plan, Do, Check, Act". 
This format allowed for an on-going process of identi .lying and 
resolving problems. Chart audits were re instituted using a differ- 
ent slant. Apberesis charts would be audited as opposed to the 
patient's entire medical record, giving a clearer picture of the con- 
tent and completeness of the documentation of the staff. Criteria 
were set for auditing donor charts; the goal was to audit 100% of 
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the charts for three months. The results of the audits were again 
discussed in staff meetings, leading to the revision of forms that 
"had been around forever". The goal was to make the forms easier 
to complete while assuring the needed information was reproted 
efficiently. Additional meetings with the staff- helped identify 
another challenge. The staff routinely reported problems occuring 
during procedures as "variances", not realizing this was a perfect 
example of Quality hnprovement. Variances are now discussed 
monthly in staff and Quality Improvement meetings and the 
results are trended. Two of the trends identified were brought o 
the attention of the equipment manufacturer. Sharing this infor- 
mation led to the re-design of a machine clip and a warning state- 
ment about hyperlipidemia patients by the companies involved. 
These are just a few of the processes that were already in place; 
the Quality Improvement Plan ahnost wrote itself. Nurses identify 
and solve problems every day. Each time this is done, the quality 
of the practice is improved. So, Interdisciplinary Teams; START 
YOUR BINDERS. 
patient was also performed. As a result, the team developed a
BMT patient education hard cover binder. The goal of the binder 
is to provide up to date, concise, and consistent educational mate- 
rial that travels with the patient across the continuum of care. The 
information contained in the binder is available on the institution- 
al web-site in an effort to pronmte asily accessed information for 
patients and staff. The content of the binder will be incorporated 
into the orientation and continuing education of new and current 
staff. Maintaining the accuracy of the information presented is 
facilitated by the ease in which the informational pages can be 
removed and replaced. The binder is designed with an easy to fol- 
low table of contents and tabulated sections for ease of use. Con- 
tents include an overview of the BMT process, side effects of 
treatment, discharge teaching, care giver information, and outpa- 
tient care. Also included are maps of the area and hospital layout, 
a business card holder, and a glossary of terms. Funding is provid- 
ed by a volunteer endowment created for patient support. A confi- 
dential patient survey is also included, which provides the basis for 
ongoing quality process improvement. 
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TIS THE SEASON TO BE SNEEZING - RSV 
Meyers, A.L; Neumam~, ft. BMT, MD /h~dersom Hom'tom TX.
One of the greatest risks for morbidity and mortality in the 
blood and marrow transplantation (BMT) patients is infection. 
The  risk is high even after engraftment, especially in those 
patients on immunosuppressive th rapy. In our BMT program we 
transplant over 500 patients per year. During the winter months 
of 2001-2002, 63 patients with documented respiratory viral 
infections were reported. Respiratory syncytial virus (RSV) 
accounted for approximately 40% of these cases. RSV is a single 
stranded RNA virus that is endemic in the community, involves 
only the respiratory tract and can remain live for up to 6 hours on 
surfaces. Ninety-four percent of viral infections found in our 
patients could be traced to community sources. The nurses and 
physicians creen for signs and symptoms of upper respiratory 
infection in the clinic prior to BMT scheduled admissions, as well 
as on our 52-bed inpatient BMT unit. A nasal wash and throat 
swab are performed and sent for viral culture and rapid viral anti- 
gen testing for any patient with positive symptoms. Admission 
may be delayed and inpatients are placed on contact isolation if 
suspicion is high or initial results positive. Visitors are also 
screened on the inpatient unit. The treatment of choice for 
patients with a positive RSV infection includes continuous or 
intermittent aerosolized ribavirin with the use of a portable hepa- 
fi ltered tent to lessen exposure of the drug to others. 
[mmunoglobulins are also used to assist the immune system to 
fight the infection. Mortality is very high in patients who develop 
pneumonia, are neutropenic or where treatment is delayed. Our 
current infection control recommendations will be presented, as 
well as aspects of the physical and psychosocial nursing care for 
this potentially life threatening diagnosis and stressful treatment 
regimen. 
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IMPROVING AND STANDARDIZING PATIENT EDUCATION: A 
PATIENT'S RESOURCE GUIDE ACCROSS THE CONTINUUM OF CARE 
FOR BLOOD AND MARROW TRANSPLANTATION 
ffezvell, ft. l SotamseJz, S. 1; Calamusa, ft. t; Ado~,netto, D.1; Ba,ghmml, 
E.Z; [ppoliti, C. l 1. ~I.D. d.de'rson Cancer Ce,ter, Housto~z, TX; 
2. M.D. Anderson Omcer Center, Hom'to~l, TX. 
Providing and maintaining up to date patient education materi- 
als is an ongoing challenge. Solving this dilemma became an iden- 
tified Quality Process Improvement goal for the BMT nursing 
leadership team for 2002. Problems identified by the multi-disci- 
plinary team included out of date, inconsistently available, and 
poorly presented materials. Our task was to look for innovative 
ideas to challenge the way things had always been done. Current 
educational materials were reviewed by the team. A review of the 
literature and evidenced-based practice in the care of the BMT 
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NURSE'S ROLE IN RECOGNIZING AND TREATING "ENGRAFTMENT 
SYNDROME" 
C, msto~, C.A.1; Nemnmm, j.3, lppollitti, C\ s i. Nursing~ 3/iDA,dersoT~ 
c:ancer Center, Ho,ston, TX; 2. 3 lDA~lderson CriTter C nte15 Houston, 
TX; 3. MDAmterso~z Grocer Cellte'G HoustoTz, TX; 4. 3/iDdndevso~ 
Ce~zcer CeTzte'G Hoztsto77, TX. 
Increasingly, nurses play a very important role in early recog- 
nition of signs and symptoms of "engraftment syndrome" (
which some call cytokine storm). If left untreated, it can be a 
serious and fatal complication for Blood and Marrow Trans- 
plantation (BMT) patients. At the time of engraftment, the clay 
preceding or post, many patients may show signs of this phe- 
nmneuon. The signs and symptoms can be a fever up to 40 
degrees C, rash, generalized and puhnonary edema. The respi- 
ratory symptoms can be severe and including diffuse alveolar 
hemorrhage (DAII). The  pat ient  may experience marked 
increase in oxygen needs ranging front room air to 80% non- 
rebreather  mask in a short  period; shortness of  breath,  
increased anxiety,, restlessness, hemoptysis and cough may be 
additional signs. It is critical for the BMT mtrse to understand 
and recognize the risks, as well as signs and symptoms with 
even subtle changes around this period of engraftment. The 
treatment the nurse would anticipate includes: stat high dose 
steroids, typically 500mg to 1Gin for 1-3 days, followed by a 
taper depending on the patient's condit ion; a stat dose of 
diuretic, usually furosemide; and potential antimicrobial therapy 
change. If DAH is suspected, The DAH Standard of Care 
(SOC) would be initiated. Transfer to the intensive care unit 
would occur, if intubation is needed. Topical steroids may be 
ordered for skin rash. It has been demonstrated in many 
patients that this complication may herald the early develop- 
ment of acute graft vs. host disease. The clinical nurse at the 
bedside plays an extremely important role in determining the 
outcome for them patient. 
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ASSESSING LEARNING NEEDS OF STEM CELL TRANSPLANT PATIENTS 
Wood, L.Ld i Rawl, S.Md I. Bone Mmv'ow Tram'plant, lmtim~a Ulli- 
vevs#_y MediLvl Center, Indianapolis, IN," 2. bzdbma University &'hool 
of Nursing, hMiannpolis, IN. 
Rapidly evolving developments in stem cell transplantation 
(SCT) present a challenge to those who educate patients undergo- 
ing this complex therapy. A prospective study using survey meth- 
ods was performed in a 14-bed Stem Cell Transplant Unit in a 
large Midwest teaching hospital. The purpose of the study was to 
assess the learning needs of stem cell transplant (SCT) patients 
upon admission to the SCT unit and again at discharge. Change 
scores were examined to determine whether p ceptions of learn 
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